Announcements Trials
Browse Landscape

Status

Completed 52Recruiting 8Withdrawn 5Terminated 4Unknown 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Endocrine 1CNS 1

Conditions

Brain Neoplasms 151Glioblastoma 147Glioma 95Neuroblastoma 50Medulloblastoma 33Central Nervous System Neoplasms 27Astrocytoma 27Neoplasms 24Ependymoma 23Sarcoma 22Carcinoma, Non-Small-Cell Lung 22Neurofibromatosis 1 21Melanoma 20Breast Neoplasms 20Rhabdomyosarcoma 18Osteosarcoma 18Sarcoma, Ewing 16Lung Neoplasms 16Gliosarcoma 16Rhabdoid Tumor 15Oligodendroglioma 15Diffuse Intrinsic Pontine Glioma 14Wilms Tumor 13Meningioma 13Hepatoblastoma 13Recurrence 12Neurofibroma, Plexiform 11Neoplasm Metastasis 11Meningeal Carcinomatosis 11Lymphoma, Non-Hodgkin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Esthesioneuroblastoma, Olfactory × CNS × Clear all
NCT04087902 2026-05-20

Long-Term Longitudinal QoL in Patients Undergoing EEA

Ohio State University

Active not recruiting
400 enrolled
CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡